Postmenopausal Clinical Trials

53 recruitingLast updated: May 21, 2026

There are 53 actively recruiting postmenopausal clinical trials across 23 countries. Studies span Not Applicable, Phase 4, Phase 2, Phase 3, Phase 1. Top locations include Lille, France, Milan, Italy, Roma, Italy. Updated daily from ClinicalTrials.gov.


Postmenopausal Trials at a Glance

53 actively recruiting trials for postmenopausal are listed on ClinicalTrialsFinder across 6 cities in 23 countries. The largest study group is Not Applicable with 25 trials, with the heaviest enrollment activity in Lille, Milan, and Roma. Lead sponsors running postmenopausal studies include 424 General Military Hospital, Massachusetts General Hospital, and Riphah International University.

Browse postmenopausal trials by phase

About Postmenopausal Clinical Trials

Looking for clinical trials for Postmenopausal? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Postmenopausal trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Postmenopausal clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 53 trials

Recruiting
Not Applicable

Acute Impact of Whey Protein-enriched Milk Fat Globule Membrane Supplementation on Postprandial Markers of Heart and Brain Health

Cardiovascular DiseasesCardiometabolic Risk FactorsCognition+2 more
Loughborough University16 enrolled1 locationNCT06953232
Recruiting

Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding

Postmenopausal Bleeding
University of Aarhus600 enrolled3 locationsNCT07400835
Recruiting
Phase 2

A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing Regimens

postmenopausal women with osteoporosis
Shenzhen Salubris Pharmaceuticals Co., Ltd.200 enrolled1 locationNCT07579936
Recruiting
Not Applicable

Cardiometabolic Adaptations to Concurrent Training: Effect of Effort Configuration on Postmenopausal Women

PostmenopausalHypertension
Universidade da Coruña60 enrolled1 locationNCT07377383
Recruiting

Bone Marrow Fat and Bariatric Surgery-Mediated Bone Loss

Bariatric Surgery in Postmenopausal Women
University Hospital, Lille40 enrolled1 locationNCT05005039
Recruiting
Phase 4

Combined Anabolic Therapy

OsteoporosisOsteoporosis, Postmenopausal
Massachusetts General Hospital50 enrolled1 locationNCT06558188
Recruiting
Not Applicable

Smart Technology-Based Intervention and Monitoring of Physical and Mental Health in Early Postmenopausal Women

PostmenopausalMenopausePostmenopausal Disorder
YI-JU TSAI90 enrolled1 locationNCT07131215
Recruiting
Not Applicable

Exercise Training and Fat Metabolism in Postmenopausal Women

ObesityPostmenopausal SymptomsPrediabetic State
Florida State University120 enrolled1 locationNCT05351476
Recruiting
Phase 1

Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers

Healthy Postmenopausal Women
Kashiv BioSciences, LLC40 enrolled2 locationsNCT06995482
Recruiting
Not Applicable

Short-term Circuit Training on Muscle Mass and Quality of Life in Sedentary Postmenopausal Women

Postmenopausal
Loma Linda University46 enrolled1 locationNCT06445842
Recruiting
Not Applicable

Effects of Lower Body EMS Training in Postmenopausal Women

SarcopeniaPostmenopausal WomenArterial Stiffness, Blood Pressure+1 more
Seoul National University39 enrolled1 locationNCT07385534
Recruiting
Phase 4

StrAtegies For Zoledronic Acid Post-dEnosumab Discontinuation in Postmenopausal oSTeoporosis

postmenopausal osteoporosis
University Hospital, Toulouse200 enrolled17 locationsNCT06767150
Recruiting
Not Applicable

Mechanisms of Anabolic Osteoporosis Therapy

Osteoporosis, Postmenopausal
Massachusetts General Hospital16 enrolled1 locationNCT05688969
Recruiting
Phase 4

Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients

OsteoporosisOsteoporosis, Postmenopausal
National Taiwan University Hospital70 enrolled1 locationNCT06938152
Recruiting
Phase 1

A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMC-003 for Injection in Healthy Postmenopausal Women

Healthy Postmenopausal Women
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.56 enrolled1 locationNCT07118085
Recruiting
Not Applicable

High Intensity Interval Training in Pre and Postmenopausal Women With Type II Diabetes.

Diabetes Mellitus, Type 2Postmenopausal Symptoms
Riphah International University45 enrolled1 locationNCT07258316
Recruiting
Not Applicable

Effect of Mechanical Loading and Bone Loss on Motor Neuron Activity-H-Reflex Relationship

Osteoporosis, Postmenopausal
Istanbul Physical Medicine Rehabilitation Training and Research Hospital24 enrolled1 locationNCT07253493
Recruiting
Not Applicable

Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis

OsteoporosisOsteoporosis, Postmenopausal
Khyber Medical University Peshawar40 enrolled1 locationNCT07242612
Recruiting
Not Applicable

Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women

Metabolic SyndromePostmenopausal Symptoms
Julie Pendergast164 enrolled1 locationNCT04893226
Recruiting
Not Applicable

Water Based Burpee Exercises on Functional Capacity in Poste-menopausal Women After Thyroidectomy

PostmenopausalFunctional CapacityBurpee Exercise+2 more
Al-Zaytoonah University of Jordan40 enrolled1 locationNCT07052279